Literature DB >> 26577272

Decreased Number of Mitochondria in Leukoaraiosis.

Zoltan Szolnoki1, Marta Szekeres2, Istvan Szaniszlo3, Gyorgy Balda3, Anita Bodor4, Andras Kondacs3, Yvette Mandi2, Ferenc Somogyvari2.   

Abstract

BACKGROUND AND AIMS: Leukoaraiosis (LA), one of the most frequent causes of an age-associated cognitive decline, can be associated with a poor quality of life, leading overall to far-reaching public health problems. Chronic hypoxia of the white matter of the brain may be a factor triggering this entity. LA may develop as a consequence of chronically insufficient cellular energy production and the accumulation of free radicals.
METHODS: In this context, after hypothesizing that the number of healthy mitochondria can be crucial in this complex process, a case-control LA study was carried out in which we analyzed the numbers of deleted and non-deleted mitochondria (the common D-loop deletion) per white blood cell. A total of 234 patients with LA and 123 MRI alteration-free subjects served as a control group.
RESULTS: Interestingly, it emerged that the ratio of deleted relative to non-deleted mitochondria is strongly associated with the risk of LA. The calculated K ratio in the LA group was significantly lower than the K ratio in the controls (LA: K 0.37 95% CI 0.05; controls: K 0.48, 95% CI 0.076, p < 0.001).
CONCLUSIONS: Our study suggests that the ratio of the dmDNA and mDNA can be of great importance in the pathogenesis of LA.
Copyright © 2015 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Energy production; Leukoaraiosis; Mitochondria; White matter damage

Mesh:

Substances:

Year:  2015        PMID: 26577272     DOI: 10.1016/j.arcmed.2015.11.002

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  5 in total

1.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

Review 2.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

Review 3.  Clinical, Radiological and Pathological Characteristics Between Cerebral Small Vessel Disease and Multiple Sclerosis: A Review.

Authors:  Bijia Wang; Xuegang Li; Haoyi Li; Li Xiao; Zhenhua Zhou; Kangning Chen; Li Gui; Xianhua Hou; Rong Fan; Kang Chen; Wenjing Wu; Haitao Li; Xiaofei Hu
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

4.  Magnetic Resonance Imaging and Clinical Features of the Demyelinating Degeneration of White Matter in Young Patients.

Authors:  Jian Li; Yi-Ming Zhao
Journal:  Int J Gen Med       Date:  2021-07-05

5.  Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation.

Authors:  Yingyan Han; Peng Wu; Zhi Wang; Zeyu Zhang; Shujuan Sun; Jia Liu; Song Gong; Peipei Gao; Tomoo Iwakuma; Miguel Angel Molina-Vila; Benjamin Ping-Chi Chen; Yu Zhang; Teng Ji; Qingqing Mo; Pingbo Chen; Junbo Hu; Shixuan Wang; Jianfeng Zhou; Hua Lu; Qinglei Gao
Journal:  EBioMedicine       Date:  2019-01-20       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.